WallStreetZenWallStreetZen

NASDAQ: PTPI
Petros Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Petros Pharmaceuticals revenue was $5.11M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $725.4k, down 54% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PTPI annual revenue was $5.1M, with -12.2% growth year-over-year.

PTPI past revenue growth

How has PTPI's revenue growth performed historically?

Company
-12.2%
Industry
10.38%
Market
20.68%
PTPI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
PTPI's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
PTPI's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

PTPI revenue history

Current Revenue
$5.1M
Current Earnings
-$26.8M
Current Profit Margin
-524.2%

Be the first to know when PTPI announces revenue.

PTPI Revenue History By Year

PTPI Yearly RevenuePTPI RevenuePTPI ChangePTPI Revenue Growth
2024-12-31$5.11M-$710.35k-12.20%
2023-12-31$5.82M-$169.67k-2.83%
2022-12-31$5.99M-$1.82M-23.29%
2021-12-31$7.81M-$1.75M-18.29%
2020-12-31$9.56M-$6.02M-38.63%
2019-12-31$15.58MN/AN/A

1 of 1

Petros Pharmaceuticals Revenue FAQ

What was PTPI's revenue last quarter?

Petros Pharmaceuticals (NASDAQ: PTPI) reported Q4 2024 revenue of $725.40 thousand up 299.15% year over year. In the same quarter last year, Petros Pharmaceuticals's revenue was -$364.25 thousand.

What was Petros Pharmaceuticals's revenue in 2024?

Petros Pharmaceuticals's annual revenue for the twelve months ending Dec 31, 2024 was $5.11 million, a 12.2% decrease year over year.

How much does Petros Pharmaceuticals make in a day?

Based on Petros Pharmaceuticals annual revenue for the past five years, PTPI makes an average of $18,793.00 per day.

What was Petros Pharmaceuticals's annual revenue growth in the past year?

As of Q2 2025, Petros Pharmaceuticals's revenue has grown -12.2% year over year. This is 22.58 percentage points lower than the US Drug Manufacturers - Specialty & Generic industry revenue growth rate of 10.38%. Petros Pharmaceuticals's revenue in the past year totaled $5.11 million.

How much does Petros Pharmaceuticals make in a year?

Petros Pharmaceuticals's revenue by year for the past five years is:
  • Petros Pharmaceuticals's revenue for the twelve months ending Dec 31, 2024 was $5.11 million, a 12.2% decrease year over year.
  • Petros Pharmaceuticals's annual revenue for Dec 31, 2023 was $5.82 million, a 2.83% decrease from 2022.
  • Petros Pharmaceuticals's annual revenue for 2022 was $5.99 million, a 23.29% decrease from 2021.
  • Petros Pharmaceuticals's annual revenue for 2021 was $7.81 million, a 18.29% decrease from 2020.
  • Petros Pharmaceuticals's annual revenue for 2020 was $9.56 million, a 38.63% decrease from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.